Patent Term Extended Under 35 U.S.C.  156

   An interim extension of the term of U.S. Patent No. Re. 34,617 has been
granted under 35 U.S.C.    156(e)((2) for a period of one year from the
extended expiration date of the patent. The patent has twice been
extended for one year under 35 U.S.C.    156(d)(5). See 1159 OG 77,
February 22, 1994, and 1171 OG 32, February 14, 1995. An application for
patent term extension was filed, on January 24, 1996, by The Procter and
Gamble Company, based on approval of the food additive product "olestra"
by the Food and Drug Administration (FDA) on January 24, 1996. The
initial PTO review of the application to date indicates that the patent
would now be eligible for a maximum extension of the patent term for a
period of two years from the date of approval by the FDA (January 24,
1996) under 35 U.S.C.      156(g)(6)(C) and (d)(5)(E)(ii).